2401 ELLIOTT AVENUE, SEATTLE, WA
Market cap: $204.4M (12/18/2025)
Price: $2.75
Investor Presentation
Provides Recent Business Highlights and Reports 3Q 2025 Results
Amended Employment Agreements for Executives at Perspective Therapeutics
Appoints Biotech Veteran Joel Sendek as Chief Financial Officer
Appoints Maya Martinez-Davis to Board of Directors
Q2
Q1
Amended Annual Report
FY 2024
Q3
FY 2023
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Prospectus filed pursuant to Rule 424(b)(3)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Specialized Disclosure Report
Post-Effective Amendment to Registration Statement
Automatic Shelf Registration Statement
Free Writing Prospectus
Correspondence